394 related articles for article (PubMed ID: 38406978)
21. Gastrointestinal involvement in patients with systemic sclerosis.
Wielosz E; Borys O; Zychowska I; Majdan M
Pol Arch Med Wewn; 2010 Apr; 120(4):132-6. PubMed ID: 20424538
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal manifestations of scleroderma.
Young MA; Rose S; Reynolds JC
Rheum Dis Clin North Am; 1996 Nov; 22(4):797-823. PubMed ID: 8923597
[TBL] [Abstract][Full Text] [Related]
23. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis.
Abignano G; Mennillo GA; Lettieri G; Karadag DT; Carriero A; Padula AA; Del Galdo F; Khanna D; D'Angelo S
J Rheumatol; 2021 Sep; 48(9):1422-1426. PubMed ID: 33452163
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma.
Bharadwaj S; Tandon P; Gohel T; Corrigan ML; Coughlin KL; Shatnawei A; Chatterjee S; Kirby DF
J Clin Gastroenterol; 2015 Aug; 49(7):559-64. PubMed ID: 25992813
[TBL] [Abstract][Full Text] [Related]
25. [Gastrointestinal involvement in systemic sclerosis].
Marie I
Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
[TBL] [Abstract][Full Text] [Related]
26. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis.
Bae S; Allanore Y; Furst DE; Bodukam V; Coustet B; Morgaceva O; Maranian P; Khanna D
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):57-63. PubMed ID: 23910611
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal Tract Considerations: Part II: How Should a Rheumatologist Best Manage Common Lower Gastrointestinal Tract Complaints in Systemic Sclerosis?
Quinlivan A; McMahan ZH; Lee EB; Nikpour M
Rheum Dis Clin North Am; 2023 May; 49(2):319-336. PubMed ID: 37028837
[TBL] [Abstract][Full Text] [Related]
28. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal involvement in systemic sclerosis: an update.
McMahan ZH
Curr Opin Rheumatol; 2019 Nov; 31(6):561-568. PubMed ID: 31389815
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal motility disorder assessment in systemic sclerosis.
Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
[TBL] [Abstract][Full Text] [Related]
31. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
[TBL] [Abstract][Full Text] [Related]
32. GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
Tétreault MP; Kahrilas P
Curr Rheumatol Rep; 2019 Jul; 21(8):42. PubMed ID: 31270707
[TBL] [Abstract][Full Text] [Related]
33. Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration.
Matsuda KM; Yoshizaki A; Kuzumi A; Toyama S; Awaji K; Miyake T; Sato S
Rheumatology (Oxford); 2023 Sep; 62(9):3139-3145. PubMed ID: 36825818
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.
McMahan ZH; Frech T; Berrocal V; Lim D; Bruni C; Matucci-Cerinic M; Smith V; Melsens K; Proudman S; Zhang J; Mendoza F; Woods M; Khanna D
J Rheumatol; 2019 Jan; 46(1):78-84. PubMed ID: 30442827
[TBL] [Abstract][Full Text] [Related]
35. Early endoscopy in systemic sclerosis without gastrointestinal symptoms.
Thonhofer R; Siegel C; Trummer M; Graninger W
Rheumatol Int; 2012 Jan; 32(1):165-8. PubMed ID: 20711592
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal involvement in systemic sclerosis: diagnosis and management.
McMahan ZH; Hummers LK
Curr Opin Rheumatol; 2018 Nov; 30(6):533-540. PubMed ID: 30234725
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.
Forbes A; Marie I
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii36-9. PubMed ID: 19487222
[TBL] [Abstract][Full Text] [Related]
38. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis.
Omair MA; Lee P
J Rheumatol; 2012 May; 39(5):992-6. PubMed ID: 22467930
[TBL] [Abstract][Full Text] [Related]
39. The microbiome and systemic sclerosis: A review of current evidence.
Tan TC; Noviani M; Leung YY; Low AHL
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
[TBL] [Abstract][Full Text] [Related]
40. Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis.
Nagaraja V; Hays RD; Khanna PP; Spiegel BM; Chang L; Melmed GY; Bolus R; Khanna D
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1725-30. PubMed ID: 24692332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
